Cardiometabolic risk factors trend in Iranian adults with hypertension over 15 years: findings of nationwide steps of 2007-2021.

IF 1.8 Q4 ENDOCRINOLOGY & METABOLISM Journal of Diabetes and Metabolic Disorders Pub Date : 2024-09-23 eCollection Date: 2024-12-01 DOI:10.1007/s40200-024-01498-0

Akbar Jafari, Seyed Hamidreza Mirbehbahani, Ali Golestani, Akbar Soltani, Sayed Mahmoud Sajjadi-Jazi, Sepehr Khosravi, Ozra Tabatabaei-Malazy, Farshad Farzadfar, Bagher Larijani

{"title":"Cardiometabolic risk factors trend in Iranian adults with hypertension over 15 years: findings of nationwide steps of 2007-2021.","authors":"Akbar Jafari, Seyed Hamidreza Mirbehbahani, Ali Golestani, Akbar Soltani, Sayed Mahmoud Sajjadi-Jazi, Sepehr Khosravi, Ozra Tabatabaei-Malazy, Farshad Farzadfar, Bagher Larijani","doi":"10.1007/s40200-024-01498-0","DOIUrl":null,"url":null,"abstract":"Objectives: People with hypertension are more susceptible to developing cardiometabolic risk factors including overweight, obesity, diabetes mellitus, dyslipidemia, and metabolic syndrome (MetS). We aim to determine the trends in the prevalence of these risk factors among Iranian adults with hypertension from 2007 to 2021.Methods: We utilized data for adults from 25 to 64 years old from four rounds of the STEPwise approach to non-communicable diseases risk factor surveillance (STEPS) study conducted in Iran in 2007, 2011, 2016, and 2021. Direct standardization by age, sex, and residency area was conducted using the 2016 Iranian census population. Weighted least squares linear regression was performed to assess the statistical changes in the trends.Results: Overall, 21,088 participants were included in this study. From 2007 to 2021, the standardized prevalence of hypertension among adults did not change significantly (from 24.5 to 22.8%). Dyslipidemia was the most prevalent comorbidity among adults with hypertension (from 83.7 to 85.5%). The standardized prevalence of overweight (39.3-40.4%) did not change significantly among adults with hypertension, while the standardized prevalence of obesity (34.3-38.4%), diabetes (10.3-13.5%), and MetS (64.4-78.3%) increased significantly, with MetS showing the highest annually change (0.9%). Considering changes in specific subgroups, significant increases in obesity were observed in males, the 45-54 age group, and rural subgroups. For MetS and diabetes, all subgroups showed a significant increase, except for diabetes in age groups, where significant increases were limited to the 55-64 age group.Conclusions: There has been a significant increase in the prevalence of obesity, diabetes, and MetS among adults with hypertension in Iran. The observed disparities in these trends across different subgroups highlight the need for health policymakers to implement targeted strategies that account for age, sex, and area differences to effectively prevent and control these risk factors.Supplementary information: The online version contains supplementary material available at 10.1007/s40200-024-01498-0.","PeriodicalId":15635,"journal":{"name":"Journal of Diabetes and Metabolic Disorders","volume":"23 2","pages":"2315-2328"},"PeriodicalIF":1.8000,"publicationDate":"2024-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11599658/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Diabetes and Metabolic Disorders","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s40200-024-01498-0","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/12/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}

引用次数: 0

Abstract

Objectives: People with hypertension are more susceptible to developing cardiometabolic risk factors including overweight, obesity, diabetes mellitus, dyslipidemia, and metabolic syndrome (MetS). We aim to determine the trends in the prevalence of these risk factors among Iranian adults with hypertension from 2007 to 2021.

Methods: We utilized data for adults from 25 to 64 years old from four rounds of the STEPwise approach to non-communicable diseases risk factor surveillance (STEPS) study conducted in Iran in 2007, 2011, 2016, and 2021. Direct standardization by age, sex, and residency area was conducted using the 2016 Iranian census population. Weighted least squares linear regression was performed to assess the statistical changes in the trends.

Results: Overall, 21,088 participants were included in this study. From 2007 to 2021, the standardized prevalence of hypertension among adults did not change significantly (from 24.5 to 22.8%). Dyslipidemia was the most prevalent comorbidity among adults with hypertension (from 83.7 to 85.5%). The standardized prevalence of overweight (39.3-40.4%) did not change significantly among adults with hypertension, while the standardized prevalence of obesity (34.3-38.4%), diabetes (10.3-13.5%), and MetS (64.4-78.3%) increased significantly, with MetS showing the highest annually change (0.9%). Considering changes in specific subgroups, significant increases in obesity were observed in males, the 45-54 age group, and rural subgroups. For MetS and diabetes, all subgroups showed a significant increase, except for diabetes in age groups, where significant increases were limited to the 55-64 age group.

Conclusions: There has been a significant increase in the prevalence of obesity, diabetes, and MetS among adults with hypertension in Iran. The observed disparities in these trends across different subgroups highlight the need for health policymakers to implement targeted strategies that account for age, sex, and area differences to effectively prevent and control these risk factors.

Supplementary information: The online version contains supplementary material available at 10.1007/s40200-024-01498-0.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

伊朗15岁以上高血压成人的心脏代谢危险因素趋势：2007-2021年全国步骤的结果

目的：高血压患者更容易发生心脏代谢危险因素，包括超重、肥胖、糖尿病、血脂异常和代谢综合征（MetS）。我们的目标是确定2007年至2021年伊朗成年高血压患者中这些危险因素的流行趋势。方法：我们利用2007年、2011年、2016年和2021年在伊朗进行的四轮非传染性疾病风险因素监测（STEPS）研究中25至64岁成年人的数据。使用2016年伊朗人口普查人口进行了年龄、性别和居住地的直接标准化。采用加权最小二乘线性回归评估趋势的统计变化。结果：本研究共纳入21,088名参与者。从2007年到2021年，成人高血压标准化患病率没有显著变化（从24.5%到22.8%）。血脂异常是成人高血压患者中最常见的合并症（从83.7%到85.5%）。成人高血压患者超重标准化患病率（39.3-40.4%）无明显变化，而肥胖（34.3-38.4%）、糖尿病（10.3-13.5%）和MetS（64.4-78.3%）的标准化患病率显著增加，其中MetS的年变化最高（0.9%）。考虑到特定亚组的变化，在男性、45-54岁年龄组和农村亚组中观察到肥胖的显著增加。对于met和糖尿病，所有亚组都显示出显著增加，除了糖尿病年龄组，显著增加仅限于55-64岁年龄组。结论：伊朗成年高血压患者中肥胖、糖尿病和MetS的患病率显著增加。观察到的这些趋势在不同亚组之间的差异突出了卫生政策制定者需要实施考虑到年龄、性别和地区差异的有针对性的战略，以有效预防和控制这些风险因素。补充资料：在线版本提供补充资料，网址为10.1007/s40200-024-01498-0。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Journal of Diabetes and Metabolic Disorders Medicine-Internal Medicine

CiteScore

4.80

自引率

3.60%

发文量

210

期刊介绍： Journal of Diabetes & Metabolic Disorders is a peer reviewed journal which publishes original clinical and translational articles and reviews in the field of endocrinology and provides a forum of debate of the highest quality on these issues. Topics of interest include, but are not limited to, diabetes, lipid disorders, metabolic disorders, osteoporosis, interdisciplinary practices in endocrinology, cardiovascular and metabolic risk, aging research, obesity, traditional medicine, pychosomatic research, behavioral medicine, ethics and evidence-based practices.As of Jan 2018 the journal is published by Springer as a hybrid journal with no article processing charges. All articles published before 2018 are available free of charge on springerlink.Unofficial 2017 2-year Impact Factor: 1.816.